Review




Structured Review

Fuzheng Pharmaceutical Co Ltd aidi injection
Aidi Injection, supplied by Fuzheng Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc12856469-168-19-8
Average 86 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Injection:

Article Title: Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
Article Snippet: .. There were 11 CHIs involved, which included Aidi Injection plus DP (20 articles), Shenqi Fuzheng Injection plus DP (11 articles), Shenfu Injection plus DP (5 articles), Compound Kushen Injection plus DP (12 articles), Kangai Injection plus DP (14 articles), Brucea Javanica Oil Milk Injection plus DP (5 articles), Shenmai Injection plus DP (3 articles), Cinobufacini Injection plus DP (2 articles), Xiaoaiping Injection plus DP (2 articles), Kanglaite Injection plus DP (10 articles), and Astragalus Injection combined with DP (1 article). ..

Article Title: Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.
Article Snippet: Colorectal cancer (CRC) is the third most common malignant tumor and the second leading cause of death from malignant tumors worldwide.. China accounts for approximately 30% of global CRC cases, and >75% of those in East Asia, in terms of both incidence and mortality.. Symptoms of CRC include abdominal pain, changes in bowel habits, and weight loss, which can significantly affect patients' quality of life (QOL).

Article Title: Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine.
Article Snippet: Argon-helium (Ar-He) knife cryosurgery therapy is a new micro-traumatic treatment for tumors.. The therapy has yielded satisfactory results in treating nonsmall cell lung cancer (NSCLC) with its simple operation, assured orientation, and limited wounds on patients.. As a kind of local therapy, it could obtain obvious long-term effect when combined with other therapeutic methods.

Article Title: Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.
Article Snippet: Objective This study conducted a network meta-analysis to comprehensively compare the efficacy and safety of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.. Methods We searched relevant previous studies from databases including Pubmed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Service System (SinMed), VIP, and Wanfang Database.. The searched studies spanned from the inception of databases to December 2022.

Article Title: Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
Article Snippet: .. The results indicated that seven regimens, including Aidi Injection plus DP (RR = 1.24, 95% CI: 1.12, 1.38), Astragalus Injection plus DP (RR = 1.77, 95% CI: 1.15, 2.92), Kangai Injection plus DP (RR = 1.35, 95% CI: 1.19, 1.55), Kanglaite Injection plus DP (RR = 1.23, 95% CI: 1.10, 1.39), Compound Kushen Injection plus DP (RR = 1.29, 95% CI: 1.16, 1.45), Shenqi Fuzheng Injection plus DP (RR = 1.33, 95% CI: 1.15, 1.55), and Brucea Javanica Oil Milk Injection plus DP (RR = 1.26, 95% CI: 1.09, 1.48), were superior to DP alone in improving the response rate, and the differences were statistically significant. ..

Article Title: Traditional Chinese medicine for non-small cell lung carcinoma: An evidence mapping
Article Snippet: .. For patients experiencing chemotherapy-induced bone marrow suppression, Shenqi Fuzheng Injection (with 13 reviews reporting positive effects on leukopenia) and Aidi Injection (12 reviews) were the most frequently supported interventions for mitigating hematological toxicity. .. Regarding the improvement of quality of life, a critical patient-centered outcome, Kanglaite Injection (positively reported in 20 reviews), Aidi Injection (20 reviews), and Compound Kushen Injection (14 reviews) emerged as the interventions with the most substantial supportive evidence.

Article Title: Efficacy and safety of commercial Chinese polyherbal preparation combined with oxaliplatin-based chemotherapy for gastric cancer: a systematic review and network meta-analysis
Article Snippet: .. A total of 27 CCPPs were compared in the network , of which, Aidi Injection combined with OX (n = 26), Compound Kushen Injection combined with OX (n = 26), and Shenqi Fuzheng Injection combined with OX (n = 32) were the most frequent treatment. ..

Milk:

Article Title: Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
Article Snippet: .. There were 11 CHIs involved, which included Aidi Injection plus DP (20 articles), Shenqi Fuzheng Injection plus DP (11 articles), Shenfu Injection plus DP (5 articles), Compound Kushen Injection plus DP (12 articles), Kangai Injection plus DP (14 articles), Brucea Javanica Oil Milk Injection plus DP (5 articles), Shenmai Injection plus DP (3 articles), Cinobufacini Injection plus DP (2 articles), Xiaoaiping Injection plus DP (2 articles), Kanglaite Injection plus DP (10 articles), and Astragalus Injection combined with DP (1 article). ..

Article Title: Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis
Article Snippet: .. The results indicated that seven regimens, including Aidi Injection plus DP (RR = 1.24, 95% CI: 1.12, 1.38), Astragalus Injection plus DP (RR = 1.77, 95% CI: 1.15, 2.92), Kangai Injection plus DP (RR = 1.35, 95% CI: 1.19, 1.55), Kanglaite Injection plus DP (RR = 1.23, 95% CI: 1.10, 1.39), Compound Kushen Injection plus DP (RR = 1.29, 95% CI: 1.16, 1.45), Shenqi Fuzheng Injection plus DP (RR = 1.33, 95% CI: 1.15, 1.55), and Brucea Javanica Oil Milk Injection plus DP (RR = 1.26, 95% CI: 1.09, 1.48), were superior to DP alone in improving the response rate, and the differences were statistically significant. ..

Emulsion:

Article Title: Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application.
Article Snippet: Colorectal cancer (CRC) is the third most common malignant tumor and the second leading cause of death from malignant tumors worldwide.. China accounts for approximately 30% of global CRC cases, and >75% of those in East Asia, in terms of both incidence and mortality.. Symptoms of CRC include abdominal pain, changes in bowel habits, and weight loss, which can significantly affect patients' quality of life (QOL).

Article Title: Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.
Article Snippet: Objective This study conducted a network meta-analysis to comprehensively compare the efficacy and safety of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.. Methods We searched relevant previous studies from databases including Pubmed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Service System (SinMed), VIP, and Wanfang Database.. The searched studies spanned from the inception of databases to December 2022.



Similar Products

86
Fuzheng Pharmaceutical Co Ltd aidi injection
Aidi Injection, supplied by Fuzheng Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc12856469-168-19-8
Average 86 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

99
Beyotime aidi injection
Aidi Injection, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/DAPI/pm41430119-126-23-35
Average 99 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
KangLaiTe aidi injection
Chinese herbal drugs reviewed
Aidi Injection, supplied by KangLaiTe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc11545508-429-10-45
Average 90 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Fuzheng Pharmaceutical Co Ltd aidi injection ad
League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: <t>CKI,</t> compound <t>Kushen</t> <t>injection;</t> KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of <xref ref-type=Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86). " width="250" height="auto" />
Aidi Injection Ad, supplied by Fuzheng Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc10681939-52-5-19
Average 90 stars, based on 1 article reviews
aidi injection ad - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Chinese herbal drugs reviewed

Journal: Molecular Cancer

Article Title: Traditional Chinese medicine in treating upper digestive tract cancers

doi: 10.1186/s12943-024-02149-x

Figure Lengend Snippet: Chinese herbal drugs reviewed

Article Snippet: Seven of the 17 CHDs described in this section, including Aidi Injection (CEA, CA125, CA199, and CA242) [ , ], Modified Bazhen Tang [CEA, CA19-9, insulin-like growth factor 1 (IGF-1) and platelet endothelial cell adhesion molecule (PECAM-1)] [ ], Chanpi Ezhu Tang (CA19-9) [ ], Kanglaite Injection (CEA and CA19-9) [ ], Kuerle Hospital-prepared Decoction (CEA, CA19-9, CA125, CA242, and VEGF) [ ], Sanleng Ezhu Decoction (CA125, CA72-4, CEA, and VEGF) [ ], and The Second Hospital of Jiaxing-prepared Decoction (VEGF, TIMP1, and MMP-9) [ ], in combination with SOX regimen respectively exerted better effects in down-regulating serum levels of tumor markers than SOX regimen alone.

Techniques: Injection, Modification

League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of <xref ref-type=Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86). " width="100%" height="100%">

Journal: Integrative Medicine Research

Article Title: Chinese herbal injections in combination with radiotherapy for advanced pancreatic cancer: A systematic review and network meta-analysis

doi: 10.1016/j.imr.2023.101004

Figure Lengend Snippet: League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86).

Article Snippet: The CHIs of interest included CKI, Aidi injection (AD), Huachansu injection (HCS), Tongguanteng injection (TGT), Yadanzi injection (YDZ), Shenqi Fuzheng injection (SQFZ), Polyporus umbellatus polysaccharide injection (PUP), Kangai injection (KA), Kanglaite injection (KLT), Astragalus polysaccharide injection (APS), and Shenmai injection (SM).

Techniques: Injection

Rank-heat plot. Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SQFZ, Shenqi Fuzheng injection; SM, Shenmai injection. The numbers represent SUCRA values. A higher SUCRA value indicates improved ORR, enhanced KPS, extended OS, and reduced incidence of leukopenia and nausea/vomiting.

Journal: Integrative Medicine Research

Article Title: Chinese herbal injections in combination with radiotherapy for advanced pancreatic cancer: A systematic review and network meta-analysis

doi: 10.1016/j.imr.2023.101004

Figure Lengend Snippet: Rank-heat plot. Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SQFZ, Shenqi Fuzheng injection; SM, Shenmai injection. The numbers represent SUCRA values. A higher SUCRA value indicates improved ORR, enhanced KPS, extended OS, and reduced incidence of leukopenia and nausea/vomiting.

Article Snippet: The CHIs of interest included CKI, Aidi injection (AD), Huachansu injection (HCS), Tongguanteng injection (TGT), Yadanzi injection (YDZ), Shenqi Fuzheng injection (SQFZ), Polyporus umbellatus polysaccharide injection (PUP), Kangai injection (KA), Kanglaite injection (KLT), Astragalus polysaccharide injection (APS), and Shenmai injection (SM).

Techniques: Injection